"id","instanceType","description","name","uuid:ID","text","label"
"Objective_1","OBJECTIVE","Main objective","OBJ1","271ed8e8-c003-41c3-be58-6f51c13e2c5b","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).",""
"Objective_2","OBJECTIVE","Safety","OBJ2","39ad3e0a-a8cd-4f96-9c28-f8628aed9bf4","To document the safety profile of the xanomeline TTS.",""
"Objective_3","OBJECTIVE","Behaviour","OBJ3","435b289b-51df-4997-b175-2088fa85d297","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.",""
